Operating

Investing and Financing Gains (Losses), Net

Abbott Investing and Financing Gains (Losses), Net remained flat by 0.0% to -$16.25M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 86.5%, from -$120.50M to -$16.25M. Over 4 years (FY 2021 to FY 2025), Investing and Financing Gains (Losses), Net shows a downward trend with a 4.3% CAGR.

Analysis

StatementCash Flow Statement
SectionOperating
First reportedQ1 2013
Last reportedQ4 2025Feb 20, 2026
Metric ID: abt_investing_and_financing_gains_losses

Historical Data

5 years
 FY'21FY'22FY'23FY'24FY'25
Value-$55.00M-$215.00M-$126.00M-$482.00M-$65.00M
YoY Change—-290.9%+41.4%-282.5%+86.5%
Range-$482.00M – -$55.00M
CAGR+4.3%
Avg YoY Growth-111.4%
Median YoY Growth-120.6%

Frequently Asked Questions

What is Abbott's investing and financing gains (losses), net?
Abbott (ABT) reported investing and financing gains (losses), net of -$16.25M in Q4 2025.
How has Abbott's investing and financing gains (losses), net changed year-over-year?
Abbott's investing and financing gains (losses), net increased by 86.5% year-over-year, from -$120.50M to -$16.25M.
What is the long-term trend for Abbott's investing and financing gains (losses), net?
Over 4 years (2021 to 2025), Abbott's investing and financing gains (losses), net has grown at a 4.3% compound annual growth rate (CAGR), from -$55.00M to -$65.00M.